Clinical Trials
- Leukemia
A Randomized, Open-Label, Phase 1-2 Study of ASTX727 Low Dose (ASTX727 LD) Extended Schedule in Subjects With Lower Risk (IPSS Low or Intermediate-1) Myelodysplastic Syndromes (MDS)
- Gynecological Cancers
A Randomized, Phase 3, Double-Blind Study of Chemoradiotherapy With or Without Pembrolizumab for the Treatment of High-risk, Locally Advanced Cervical Cancer (KEYNOTE-A18 / ENGOT-cx11)
- Lymphoma
A Randomized, Phase IIB, Multicenter, Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in Patients With Relapse or Refractory Peripheral T-cell Lymphoma (PTCL)
- Lung Cancer
A Randomized, Phase III Study of Firstline Immunotherapy Alone or in Combination With Chemotherapy in Induction/Maintenance or Postprogression in Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC) With Immunobiomarker SIGNature-Driven Analysis
- Breast Cancer
A Safety Study of SGN-LIV1A in Breast Cancer Patients
- Ages18 years and older
- GenderFemale only
- Children's Health
A Short-Term Longitudinal Study of the Brain Mechanisms of Childhood Irritability
- Ages8 years - 15 years
- GenderBoth
- HIV/AIDS, Infectious Disease, Tobacco Addiction
A Smart Approach to Treating Tobacco Use Disorder in Persons Living With HIV (SMARTTT)
- Ages18 years and older
- GenderBoth
- Alzheimer's
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
- Ages60 years - 85 years
- GenderBoth
- Leukemia, Pediatric Cancers, Sickle Cell Disorders
A Study of Hematopoietic Stem Cell Transplantation (HSCT) in Non-Malignant Disease Using a Reduced-Intensity Preparatory Regime
- COVID-19 Inpatient, COVID-19 Outpatient
A Study of LAM-002A for the Prevention of Progression of COVID-19
- Ages18 years and older
- GenderBoth